Hamilton Thorne (CVE:HTL) Stock Price Up 4.3% – Still a Buy?

Hamilton Thorne Ltd. (CVE:HTL)’s stock price shot up 4.3% on Wednesday . The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Performance

The company has a debt-to-equity ratio of 33.94, a quick ratio of 2.25 and a current ratio of 2.63. The company has a market cap of C$212.89 million, a P/E ratio of 48.33 and a beta of 0.54. The firm has a 50 day moving average price of C$1.45 and a 200-day moving average price of C$1.45.

Insider Buying and Selling

In other news, insider AWM Investment Company, Inc. bought 783,000 shares of the stock in a transaction that occurred on Thursday, October 10th. The shares were acquired at an average cost of C$1.56 per share, for a total transaction of C$1,221,010.20. Corporate insiders own 29.41% of the company’s stock.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets.